Arizona lawmakers poised to approve kratom regulations




Photo by Dominic Milton Trott | Flickr/CC BY-SA 2.0

Lawmakers are planning to regulate a substance called kratom that is still undergoing evaluations by federal agencies, such as the Drug Enforcement Agency and the Food and Drug Administration, and has been making medical professionals nervous.

“Is it just me that doesn’t know what kratom is?” Sen. Michelle Ugenti-Rita, R-Scottsdale, said during a Senate Appropriations Committee hearing of House Bill 2550.

The measure, sponsored by Rep. Tony Rivero, R-Peoria, would disallow the sale of kratom to anyone under the age of 18 and requires sellers of the product to disclose what all is in their kratom based products on top of other regulatory measures.

Rivero calls it the “Kratom Consumer Protection Act.”

Arizona is not alone in how it is trying to tackle regulation of a new drug that is mostly unknown and has entities like the Center for Disease Control and the Drug Enforcement Agency working to determine how to deal with it.

But what is kratom, why is there a need for regulation and how is the federal government handling this somewhat new and unique drug?

What is kratom?

Mitragyna speciosa is the latin name for kratom, a plant that is native to Southeast Asia and is related to the coffee plant.

The plant is often ground up into powder which can be taken in pill form, smoked or turned into tea.

Ingesting the plant can give a stimulant effect in low doses, but it has a sedative effect in higher doses. The drug interacts with many of the same receptors in the brain that opioids do. Because of that, many advocates say kratom can be used as an alternative to opioids and can be a tool to fight opioid addiction.

Its been on the DEA’s radar since 2011, according to DEA spokeswoman Katherine Pfaff. The agency has had it listed as a “drug of concern” since then.


Drugslab is a YouTube channel funded by the Dutch Government aimed at aiding in education around drug use.

In 2016, the DEA published in the federal registrar that it intends to classify it as a Schedule I drug, placing it alongside heroin, LSD and cocaine. When a drug is classified under Schedule I, it is deemed to have “no medical use.”

However, advocates for the use of kratom who made a variety of claims on the positive impacts of the drug led to the DEA withdrawing its intent to classify kratom in that manner.

Now the DEA is waiting on the Food and Drug Administration to complete a medical and scientific review of the main components of kratom, mitragynine and 7-hydroxymitragynine.

The DEA received more than 23,000 comments after initially calling for kratom to be classified as a Schedule I drug.

The process of reviewing kratom medically and scientifically could take years, Pfaff said.

If Arizona were to pass the bill and the DEA decided to classify kratom as a Schedule I substance, then the “more stringent” federal rules would apply, Pfaff said.

A lack of data

However, federal agencies are already sounding off on some of their concerns around kratom.

[T]here have been no adequate and well-controlled scientific studies involving the use of kratom as a treatment for opioid use withdrawal or other diseases in humans,” FDA Commissioner Dr. Scott Gottlieb said in a statement released last year on the FDA’s stance on the drug. “[I]ts use has been on the rise and is of concern to the FDA.”

In one of the first federal studies of the drug, the Centers for Disease Control was able to link kratom to a number of overdose deaths. Of 152 people found to have kratom in their system at the time of death, 91 were ruled to have been caused entirely by kratom. However, the data only came from a few select states during a small period of time.

Part of the problem with determining the potential harm of kratom is due to the fact that many users often mix it with other drugs.

Additionally, conducting toxicology tests for kratom is especially difficult, according to Dr. Traci Pritchard, president of the Arizona Medical Association, also known as ArMA.

Currently, if a patient comes into an emergency room, there is no standardized test for kratom exposure. If a doctor wants to determine if kratom was in a patient’s system, they’d likely have to send their samples to a national laboratory and wait for the results, Pritchard said.

Current toxicology screenings used by doctors across Arizona don’t show kratom in their results. This means that even if medical professionals in Arizona wanted to know how often kratom is being used by patients they may be seeing, it would likely be impossible or incredibly difficult to find out.

“Without more data, we just don’t know,” Pritchard said.

That lack of data also applies to claims by pro-Kratom advocates who say the drug is an alternative to opioids.

“There’s only anecdotal evidence of it helping with pain,” Pritchard said, adding that “anecdotal evidence is not scientific evidence.”

Pritchard and ArMA are in support of Rivero’s bill to regulate the sale and use of kratom, as they believe that the current lack of regulations is detrimental, specifically to children.

Oregon is currently debating a similar measure, and Utah is poised to do the same.

Kratom is outright banned in five states and several municipalities across the country.

Rivero’s bill has seen strong bipartisan support and is expected to be considered soon by the House of Representatives for a final vote. If the House approves it, the measure would go to Gov. Doug Ducey for him to sign or veto.

Jerod MacDonald-Evoy
Reporter Jerod MacDonald-Evoy joins the Arizona Mirror from the Arizona Republic, where he spent 4 years covering everything from dark money in politics to Catholic priest sexual abuse scandals. Jerod has also won awards for his documentary films which have covered issues such as religious tolerance and surveillance technology used by police. He brings strong watchdog sensibilities and creative storytelling skills to the Arizona Mirror.

5 COMMENTS

  1. Kratom has been a part of my life for over 5 years…never had any side effects other than the ability to control the chronic pain in my knees allowing me to continue working after 65! Unfortunately my doctor prescribed me painkillers after my knee surgery which led to addiction issues that were very difficult to overcome, but kratom eased the terrible withdrawals from opioids. This God given plant is a cousin to the coffee plant and will make you vomit if you take too much! Shame on the FDA for crucifying this natural plant! Praise the AKA and other advocates for saving this plant!

  2. By the numbers, kratom is safer than peanuts. Peanuts cause 150-200 death per year. There have been just over 100 kratom “related” deaths. That simply means they had kratom in their system at time of death, oncluding the murder victim, who OBVIOUSLY did not die of anything kratom-related, but it was there. if similar scrutiny was paid to caffeine, how many coffee-RELATED deaths would exist. Likely, tens of thousands of heart aytacks each year are coffee related, but such testing usn’t done – despite known stimulant properties. Why? Que Bono? We KNOW who would benefit in a financial windfall were kratom yo be banned, and that is another influence that cannot be ignored. Is is addictive? Yes, but so what? So if coffee – or anything one enjoys for that matter. Is it dangerous? No. It can’t be considered dangerous unless peanuts are also considered dangerous… and at ~1.6+ BILLION doses per year, it is consumed almost a half a billion doses per year more than Tylenol/APAP which causes 50-70,000 hospitaluzable ODs per year. The selective numbers tgey use to try to demonize a safe plany are a complete joke to anyone who knows how to consider methodology. The amount used cannot be ignored when we are trying to determine whether adverse effects constitute a “danger.”

  3. Lastly… “anecdotal” evidence supportibg pain relief? We know for a FACT, hell, thd FDA classified it as an opiate. Show me something that effects opioid receptors that does not releive pain. Tell Dr. McCurdy at UF that he never published his research to boot. And, there is this, in a medical journal, which states it clearly…

    https://jaoa.org/article.aspx?articleid=2094342

    Dr. Pritchard needs a coupole continuing education classes, and revisit what they taught her about opioid agonists in med school. (It would also do good for the author of the article to fact-check statements… but these days that seems too much to ask of “journalists.”)

  4. You people are nuts! This is a horrible horrible drug. No one should drive or work on this. It needs to be illegal ASAP and it ruins people’s lives.

LEAVE A REPLY

Please enter your comment!
Please enter your name here